Sanofi SA (SNY)

42.60
NYSE : Health Care
Prev Close 42.60
Day Low/High 0.00 / 0.00
52 Wk Low/High 37.41 / 54.98
Avg Volume 2.30M
Exchange NYSE
Shares Outstanding 2.61B
Market Cap 110.80B
EPS 1.90
P/E Ratio 22.81
Div & Yield 1.66 (3.90%)

Latest News

Sanofi Quarterly Earnings, Sales Slide, Reiterates Discipline on Medivation

The company says currency headwinds will erode 4% from full-year earnings per share.

Sanofi's Chart Shows Promise

Sanofi's Chart Shows Promise

Our first upside target is the $50 to $52 area and a close below $40 would extend the base.

Sanofi (SNY) Stock Lower Ahead of Friday’s Q2 Earnings

Sanofi (SNY) Stock Lower Ahead of Friday’s Q2 Earnings

Sanofi (SNY) stock is declining on Thursday afternoon ahead of the company’s 2016 second quarter results, due out before tomorrow’s market open.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMOT, ANGI, CBT, ELY, FTAI, GNBC, LOGM, NCR, SIX, SKUL, SLAB, SNY, SONS, TRK, TRN, UFS, VRTX, WES, ZNGA Downgrades: AF, BA, TER, WEX Initiations: FSV Read on to get TheStreet Quant Ratings' detailed report:

Sanofi Receives FDA Approval Of AdlyxinTM For Treatment Of Adults With Type 2 Diabetes

Sanofi Receives FDA Approval Of AdlyxinTM For Treatment Of Adults With Type 2 Diabetes

- AdlyxinTM is approved as Lyxumia® in more than 60 countries -

Sanofi Pasteur Ships First Of Its 2016-2017 Seasonal Influenza Vaccine Doses In United States

Sanofi Pasteur Ships First Of Its 2016-2017 Seasonal Influenza Vaccine Doses In United States

- World's largest influenza vaccine manufacturer expects to distribute more than 65 million vaccine doses to help protect people six months and older against the flu -

Biogen Should Either a Buyer or a Seller Be

Biogen Should Either a Buyer or a Seller Be

The company sans CEO Scangos needs to do some type of deal in the coming months.

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal

Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa.

Investors Scour Big Pharma M&A Scene for Next Big Takeover

Investors Scour Big Pharma M&A Scene for Next Big Takeover

Following Galenica's $1.5 billion bid for Relypsa, investors are beginning to search for the next target.

Relypsa Finally Finds Buyer, but Potential Seen For Rival Bid

Relypsa Finally Finds Buyer, but Potential Seen For Rival Bid

Shares of Relypsa are rallying after the company announced it has agreed to be acquired by Galenica Group in a $1.53B deal.

Sanofi (SNY) Moving On Heavy Volume In The Pre-Market Hours

Sanofi (SNY) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified Sanofi (SNY) as a pre-market mover with heavy volume candidate

Sanofi (SNY) Flagged As A Storm The Castle Stock

Sanofi (SNY) Flagged As A Storm The Castle Stock

Trade-Ideas LLC identified Sanofi (SNY) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

Award-Winning Chef Elizabeth Falkner Reveals Her Struggle With Atopic Dermatitis To Highlight The Physical And Psychological Impact Of The Disease

Award-Winning Chef Elizabeth Falkner Reveals Her Struggle With Atopic Dermatitis To Highlight The Physical And Psychological Impact Of The Disease

Falkner has joined forces with Regeneron and Sanofi Genzyme in collaboration with leading dermatology organizations to educate Americans about a potentially serious, chronic inflammatory skin disease known as atopic dermatitis.

Sanofi Pasteur (SNY) Partners With Walter Reed Army Institute to Create Zika Vaccine

Sanofi Pasteur (SNY) Partners With Walter Reed Army Institute to Create Zika Vaccine

Drugmaker Sanofi Pasteur has struck up a deal with the U.S. Army to come up with a vaccine for the Zika virus.

Medivation Tries to Prove Its Worth

Medivation Tries to Prove Its Worth

A call with investors Wednesday highlights drugs in the pipeline that could be attractive to bidders that reportedly include Sanofi, Pfizer and Celgene, among others.

Wall Street Closes Higher as Fed Doves Make Case for Waiting on Rates

Wall Street Closes Higher as Fed Doves Make Case for Waiting on Rates

A dovish Federal Reserve in June pushes equities, crude to close around session highs.

Stocks Add to Gains as Fed Stresses Prudence in Policy-Making

Stocks Add to Gains as Fed Stresses Prudence in Policy-Making

Stocks add to gains by late afternoon Wednesday after the Federal Reserve's June meeting minutes confirm members' prudent approach to monetary policy.

Crude Turns Lower Again as Brexit Worries Weigh on Markets

Crude Turns Lower Again as Brexit Worries Weigh on Markets

Crude oil returns to the red by late Wednesday morning, reversing a brief recovery, as stocks turn mixed.

Stock Futures Set Up for Another Decline as Crude Tumbles, Trade Gap Widens

Stock Futures Set Up for Another Decline as Crude Tumbles, Trade Gap Widens

Stock futures set up Wall Street for another slide on Wednesday as Brexit fears pull crude oil lower.

Medivation Shares Spike as Company Opens Door to Full-Fledged Auction

Medivation Shares Spike as Company Opens Door to Full-Fledged Auction

The company's shares were up nearly 2% in after hours trading.

Sanofi Genzyme Begins Pivotal Phase 2/3 Trial Of Olipudase Alfa For Adult Patients With Acid Sphingomyelinase Deficiency

Sanofi Genzyme Begins Pivotal Phase 2/3 Trial Of Olipudase Alfa For Adult Patients With Acid Sphingomyelinase Deficiency

Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that the first adult patient has enrolled and been dosed in a pivotal Phase 2/3 clinical trial named ASCEND for the investigational...

July 6 Premarket Briefing: 10 Things You Should Know

July 6 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are lower Wednesday as European shares tumble and the British pound hits a new 31-year low.

An Auction Process Could Be on Medivation's Horizon

An Auction Process Could Be on Medivation's Horizon

The biopharmaceutical company has entered into confidentiality agreements with Sanofi and others.

16 Biopharma Companies Besides Medivation That Are Attractive Targets

16 Biopharma Companies Besides Medivation That Are Attractive Targets

Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.

Sanofi (SNY) Moving On Heavy Pre-Market Trading

Sanofi (SNY) Moving On Heavy Pre-Market Trading

Trade-Ideas LLC identified Sanofi (SNY) as a pre-market mover with heavy volume candidate

Strong On High Relative Volume: Sanofi (SNY)

Strong On High Relative Volume: Sanofi (SNY)

Trade-Ideas LLC identified Sanofi (SNY) as a strong on high relative volume candidate

3 Health Care Stocks Nudging The Sector Higher

3 Health Care Stocks Nudging The Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.